4.6 Review

Headache Attributed to Reversible Cerebral Vasoconstriction Syndrome (RCVS)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Vasoconstriction and long-term headache in reversible cerebral vasoconstriction syndrome

Neha Kumar et al.

Summary: The study aims to examine the sensitivity and specificity of a newly developed score (RCVS2) for vasoconstriction detection in a real-world clinical context and describe the incidence and predictors of long-term headaches (LTH) beyond the acute phase of reversible cerebral vasoconstriction syndrome (RCVS). The results showed that approximately 50% of RCVS patients experienced LTH, and a prior history of headache was associated with its incidence. The RCVS2 score had a significant association with high specificity and positive predictive value for angiographic vasoconstriction.

JOURNAL OF NEUROLOGY (2023)

Review Neurosciences

Reversible cerebral vasoconstriction syndrome: literature review

Michelle Zonkowski Ribas et al.

Summary: Reversible Cerebral Vasoconstriction Syndrome (RCVS) is a neurovascular condition characterized by a severe sudden-onset headache that may be associated with focal neurological deficits. Imaging shows multifocal vasoconstriction of cerebral arteries, which resolves spontaneously within approximately 12 weeks. Early identification of precipitating factors and diagnosis is crucial for establishing adequate management and ensuring a good prognosis, given the risk of secondary complications and residual neurological deficits.

EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY (2023)

Review Clinical Neurology

RCVS: by clinicians for clinicians-a narrative review

Deborah Katharina Erhart et al.

Summary: Reversible cerebral vasoconstriction syndrome is a common but potentially underdiagnosed condition characterized by thunderclap headache and widespread vasoconstriction. The pathophysiology is believed to involve sympathetic overactivity and endothelial dysfunction. Precipitating factors include the use of vasoactive substances and postpartum status.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Complications of reversible cerebral vasoconstriction syndrome in relation to age

Kristin Sophie Lange et al.

Summary: Reversible cerebral vasoconstriction syndrome (RCVS) complications vary according to age, with cervical artery dissections more common in young patients and haemorrhagic complications more common in older patients. Age does not impact functional outcome.

JOURNAL OF NEUROLOGY (2023)

Article Pediatrics

Intra-arterial vasodilators infusion for management of reversible cerebral vasoconstriction syndrome in a 12-year-old girl: A case report

Frida Rizzati et al.

Summary: Reversible cerebral vasoconstriction syndrome (RCVS) is a vascular disease characterized by temporary constriction and dilation of the cerebral arteries, leading to severe acute headaches and potential neurological complications. The optimal management for RCVS remains uncertain, but calcium channel blockers have shown effectiveness in adult cases. Intra-arterial vasodilators have also been used for severe cases, although their utility in pediatric patients is still under investigation. This case report highlights the use of intra-arterial vasodilators in a 12-year-old girl with RCVS and multiple cerebral infarcts.

FRONTIERS IN PEDIATRICS (2023)

Article Clinical Neurology

Reversible cerebral Vasoconstriction syndrome intERnational CollaborativE (REVERCE) network: Study protocol and rationale of a multicentre research collaboration

Kristin Sophie Lange et al.

Summary: Reversible cerebral vasoconstriction syndrome (RCVS) is a rare cerebrovascular condition with limited knowledge about risk factors, prognosis, and optimal treatment. The REVERCE project aims to collect and analyze data from four countries to understand the epidemiological and clinical characteristics of RCVS patients. The results of this study are expected to contribute to a better understanding of RCVS.

EUROPEAN STROKE JOURNAL (2023)

Article Clinical Neurology

Transcranial Doppler findings in reversible cerebral vasoconstriction syndrome

Mausaminben Hathidara et al.

Summary: The study found that TCD is useful in detecting vasospasm and monitoring the temporal evolution of RCVS. The number of vessels with abnormal velocities gradually increases, peaks between 13 and 14 days after symptom onset, and normalizes at 60 days.

JOURNAL OF NEUROIMAGING (2022)

Article Neurosciences

Fulminant Reversible Cerebral Vasoconstriction Syndrome in Breakthrough COVID 19 Infection

Somdattaa Ray et al.

Summary: We report a case of fulminant reversible cerebrovascular constriction syndrome (RCVS) in a patient with breakthrough COVID 19 infection who was fully vaccinated. RCVS following COVID infection has been reported to have a benign outcome. However, despite vaccination, fulminant RCVS following a breakthrough COVID infection was observed in our patient.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2022)

Article Clinical Neurology

Transcranial Doppler findings in a population with clinical probable reversible cerebral vasoconstriction syndrome

R. Oliveira et al.

Summary: Transcranial Doppler (TCD) may serve as a useful tool in identifying vasospasm in patients with probable RCVS, aiding in the diagnosis of RCVS in those presenting with recurrent TCH without SAH.

REVUE NEUROLOGIQUE (2022)

Article Clinical Neurology

Type of headache at onset and risk for complications in reversible cerebral vasoconstriction syndrome

Kristin Sophie Lange et al.

Summary: Patients with reversible cerebral vasoconstriction syndrome (RCVS) who do not present with thunderclap headache (TCH) at onset have a higher risk for neurological complications, including cervical artery dissections, posterior reversible encephalopathy syndrome, seizures, and subarachnoid hemorrhage, compared to those with TCH. However, the functional outcome at 3 months is similar in both groups, with most patients having a good prognosis. Further multicentric studies are needed to confirm these findings.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Clinical Neurology

Reversible Cerebral Vasoconstriction Syndrome and Multisystem Inflammatory Syndrome in Children With COVID-19

Atefeh Sadeghizadeh et al.

Summary: This study reported two cases of pediatric COVID-19 patients with severe MIS-C and RCVS. Both patients presented with thunderclap headaches and neurological deficits, and showed marked improvement after treatment.

PEDIATRIC NEUROLOGY (2022)

Article Immunology

COVID-19 Vaccination Might Induce Reversible Cerebral Vasoconstriction Syndrome Attacks: A Case Report

Anne Marie Lund et al.

Summary: A 30-year-old male diagnosed with reversible cerebral vasoconstriction syndrome (RCVS) experienced a series of attacks resembling RCVS after receiving the first Pfizer COVID-19 vaccine. However, treatment with the angiotensin 2 receptor antagonist, losartan, proved effective in preventing further RCVS attacks.

VACCINES (2022)

Article Clinical Neurology

Case report of a fulminant non-aneurysmal convexity subarachnoid hemorrhage after COVID-19

Maximilian Scheer et al.

Summary: We report a case of fulminant non-aneurysmal subarachnoid hemorrhage after COVID-19 in a patient with no previous medical history or known illness, despite having had a COVID-19 infection one month prior. The patient had rarefied vessels in the area of the left middle cerebral artery and a massive left frontal hemorrhage on imaging, suggesting a reversible cerebral vasoconstriction syndrome (RCVS) possibly caused by COVID-19 infection, leading to the hemorrhage and ultimately brain death.

INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT (2022)

Article Clinical Neurology

Persistent brain damage in reversible cerebral vasoconstriction syndrome on 99mTc-ethyl cysteinate dimer single-photon emission computed tomography: A long-term observational study

Katsuhiko Kunitake et al.

Summary: This study investigated the application of 99mTc-ECD SPECT in the course of RCVS, showing that reduced cerebral uptake persisted in the late stage even after vasoconstriction and headache subsided. BBB breakdown and/or brain tissue damage may underlie this phenomenon, indicating 99mTc-ECD SPECT as an effective neuroimaging method to detect brain functional abnormalities throughout the treatment course of RCVS.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2022)

Article Clinical Neurology

Reversible Cerebral Vasoconstriction Syndrome in a Previously Healthy Child A Case Report

Ana Rute Manuel et al.

Summary: This case describes a healthy boy diagnosed with RCVS and PRES. The case emphasizes the interconnection between RCVS and PRES, and highlights the need to include both as differential diagnoses for severe headache, as well as the essential role of MR angiography in the investigation.

NEUROLOGY-CLINICAL PRACTICE (2022)

Review Radiology, Nuclear Medicine & Medical Imaging

Reversible cerebral vasoconstriction syndrome: review of neuroimaging findings

Teresa Perillo et al.

Summary: Reversible cerebral vasoconstriction syndrome is a group of disorders characterized by segmental narrowing and dilatation of cerebral arteries, clinically presenting with sudden-onset headaches and neurological deficits. The main imaging finding is segmental constriction of intracranial arteries, which can be associated with bleeding and cerebral edema.

RADIOLOGIA MEDICA (2022)

Review Clinical Neurology

Reversible Cerebral Vasoconstriction Syndrome in the Postpartum Period: A Systematic Review and Meta-Analysis

Kimberly Pacheco et al.

Summary: The prevalence of RCVS in the postpartum period is relatively high at 11.9%, with 52.7% of patients experiencing hemorrhagic RCVS. Among hemorrhagic RCVS patients, Intracerebral Hemorrhage (ICH) is more common than Subarachnoid Hemorrhage (SAH).

NEUROLOGY INTERNATIONAL (2022)

Article Clinical Neurology

Reversible Cerebral Vasoconstriction Syndrome in the Setting of COVID-19 and Pleomorphic Sarcoma A Case Report

Ehab Harahsheh et al.

Summary: This article discusses a possible association between COVID-19 infection and sarcomatous tumors with reversible cerebral vasonstriction syndrome (RCVS). The study suggests that symptoms similar to COVID-19 may lead to RCVS and noncatecholamine producing masses could potentially be a risk factor for RCVS.

NEUROLOGIST (2022)

Article Emergency Medicine

Posterior reversible encephalopathy syndrome associated with Henoch Schonlein Purpura in a pediatric patient

Derek J. Fikse et al.

Summary: Henoch Schonlein Purpura is a rare hypersensitivity vasculitis commonly seen in pediatric patients, presenting with purpuric rash, abdominal pain, and microscopic hematuria. Posterior Reversible Encephalopathy Syndrome, on the other hand, is a poorly understood condition associated with cerebral edema and segmental vasoconstriction, characterized by headaches, seizures, and visual changes. In this case, a 6-year-old girl developed Posterior Reversible Encephalopathy Syndrome as a complication from Henoch Schonlein Purpura.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)

Article Clinical Neurology

Hemorrhagic reversible cerebral vasoconstriction syndrome: A retrospective observational study

Smit D. Patel et al.

Summary: The study found that intracerebral hemorrhage is the most common vascular complication in hospitalized RCVS patients, leading to longer hospital stays, more invasive procedures, and higher healthcare costs. However, overall outcomes are excellent regardless of the type of intracerebral hemorrhage, with no inpatient mortality observed in patients with hemorrhagic RCVS. Female sex and middle to older age groups are associated with higher odds of intracerebral hemorrhage.

JOURNAL OF NEUROLOGY (2021)

Article Clinical Neurology

Circulating microRNAs Associated With Reversible Cerebral Vasoconstriction Syndrome

Shih-Pin Chen et al.

Summary: This study identified a panel of miRNAs that distinguished patients with RCVS from controls, with let-7a-5p, let-7b-5p, and let-7f-5p showing higher abundance in patients with ictal migraine. Target prediction and pathway analysis suggested their involvement in RCVS pathogenesis, which was confirmed in vitro. MiR-130a-3p was associated with disruption of the blood-brain barrier and increased permeability in a human BBB model.

ANNALS OF NEUROLOGY (2021)

Article Neurosciences

Reversible Cerebral Vasoconstriction Syndrome in Patients with Coronavirus Disease: A Multicenter Case Series

Kristine Arandela et al.

Summary: This study describes the clinical features, risk factors, and outcomes of RCVS in a group of COVID-19 patients. The findings suggest that COVID-19 patients may be at risk for developing RCVS, especially with additional risk factors such as exposure to vasoactive agents. There was variability in symptoms and severity of COVID-19, clinical characteristics, imaging abnormalities, and mRS scores among the patients with RCVS.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2021)

Article Clinical Neurology

Characterization of thunderclap headache in a reversible cerebral vasoconstriction syndrome case series

Jonathan H. Smith et al.

Summary: In individuals with reversible cerebral vasoconstriction syndrome (RCVS), thunderclap headache (TCH) can be identified using either a verbal descriptor scale (VDS) or numerical rating scale (NRS), with a wider range of peak intensities than previously recognized. TCH remains recognizable despite the presence of pre-existing baseline headache.

HEADACHE (2021)

Review Clinical Neurology

Reversible cerebral vasoconstriction syndrome in children: an update

Angel R. Maldonado-Soto et al.

Summary: Headaches are a common cause of emergency room visits in pediatric patients, with thunderclap headaches potentially being associated with reversible cerebral vasoconstriction syndrome (RCVS) in children. RCVS is characterized by diffuse vasoconstriction of the cerebral arterial vasculature and can lead to recurrent severe headaches, as well as focal neurological deficits. While RCVS is better understood in adults, it also occurs in children with some differences in presentation.

SEMINARS IN PEDIATRIC NEUROLOGY (2021)

Article Clinical Neurology

Quantitative arterial spin labeling magnetic resonance imaging analysis of reversible cerebral vasoconstriction syndrome: A case series

Yuya Kano et al.

Summary: This study quantified chronological cerebral blood flow changes in patients with RCVS using ASL MRI, revealing initial decreases followed by subsequent increases, especially in the second week. These changes may serve as surrogate imaging markers for RCVS-related complications.

HEADACHE (2021)

Article Clinical Neurology

Post-reversible cerebral vasoconstriction syndrome headache

Yu-Hsiang Ling et al.

Summary: This study revealed that post-RCVS headache is common, affecting half of the patients and causing moderate-to-severe disability in about one-tenth of them. Higher anxiety levels and history of migraines are identified as risk factors for post-RCVS headache. Approximately half of the patients with post-RCVS headache are estimated to recover in about a year.

JOURNAL OF HEADACHE AND PAIN (2021)

Article Clinical Neurology

Early Risk of Readmission Following Hospitalization for Reversible Cerebral Vasoconstriction Syndrome

Aayushi Garg et al.

Summary: Nearly 14% of patients with RCVS are readmitted within 90 days of discharge, with a significant proportion of readmissions due to ongoing or recurrent symptoms of RCVS. Diabetes, history of tobacco use, opioid use, and longer index hospitalization length were independent predictors of 90-day readmission.

NEUROLOGY (2021)

Article Multidisciplinary Sciences

RCVS-TCH score can predict reversible cerebral vasoconstriction syndrome in patients with thunderclap headache

Soohyun Cho et al.

Summary: A new scoring system (RCVS-TCH score) was developed to predict reversible cerebral vasoconstriction syndrome (RCVS) in patients with thunderclap headache (TCH), showing good performance with a high sensitivity and specificity in discriminating RCVS from non-RCVS. The four predictors included recurrent TCHs, female sex, triggering factor for TCH, and blood pressure surge. Validation of the RCVS-TCH score demonstrated its effectiveness in diagnosing RCVS among TCH patients.

SCIENTIFIC REPORTS (2021)

Article Clinical Neurology

Diagnosis and classification of headache associated with sexual activity using a composite algorithm: A cohort study

Po-Tso Lin et al.

Summary: This study successfully differentiated types of headaches associated with sexual activity and identified potential prognostic factors through a detailed clinical and radiological diagnostic algorithm.

CEPHALALGIA (2021)

Article Neurosciences

COVID-19 Associated Reversible Cerebral Vasoconstriction Syndrome Successfully Treated with Nimodipine and Aspirin

Tarab Mansoor et al.

Summary: Limited cases show a link between SARS-CoV-2 infection and reversible cerebral vasoconstriction syndrome (RCVS). Treatment for RCVS in the context of mild SARS-CoV-2 respiratory infection includes nimodipine and aspirin, as SARS-CoV-2 attacks ACE2 receptors, leading to vasoconstriction.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2021)

Article Clinical Neurology

Reversible Cerebral Vasoconstriction Syndrome Symptoms, Incidence, and Resource Utilization in a Population-Based US Cohort

Jessica Magid-Bernstein et al.

Summary: The study estimated the age- and sex-standardized incidence of hospitalization for reversible cerebral vasoconstriction syndrome (RCVS) in US adults to be approximately 3 cases per million per year. Many patients with RCVS had concomitant neurologic diagnoses, including subarachnoid hemorrhage, ischemic stroke, and intracerebral hemorrhage.

NEUROLOGY (2021)

Letter Clinical Neurology

A Rare Pediatric Case of Marijuana-Induced Reversible Cerebral Vasoconstriction Syndrome

Laura Bliss et al.

PEDIATRIC NEUROLOGY (2021)

Article Clinical Neurology

Early Risk of Readmission Following Hospitalization for Reversible Cerebral Vasoconstriction Syndrome

Aayushi Garg et al.

Summary: Nearly 14% of patients with reversible cerebral vasoconstriction syndrome (RCVS) are readmitted within 90 days of discharge, with factors such as diabetes, history of tobacco use, opioid use, and longer length of index hospitalization being independent predictors of readmission. The most common reasons for readmissions are acute cerebrovascular events, continued or recurrent RCVS symptoms, infections, and headache, with a significant proportion of patients not being discharged to home after readmission.

NEUROLOGY (2021)

Article Clinical Neurology

Illicit Drugs and Reversible Cerebral Vasoconstriction Syndrome

Katherine Short et al.

Summary: The study found cannabis to be the strongest evidence for being associated with reversible cerebral vasoconstriction syndrome (RCVS), while other illicit drugs lacked support as individual precipitating factors. Inconsistency in the application of diagnostic criteria for RCVS was also identified, hindering advancements in knowledge in this field. Consistent adherence to diagnostic criteria and establishment of a prospective registry of RCVS cases are important for future studies to advance understanding of the condition and its underlying causes.

NEUROHOSPITALIST (2021)

Article Clinical Neurology

Long-Term Outcomes After Reversible Cerebral Vasoconstriction Syndrome

Rosalie Boitet et al.

STROKE (2020)

Article Neurosciences

Reversible cerebral vasoconstriction syndrome and dissection in the setting of COVID-19 infection

Katarina Dakay et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2020)

Review Clinical Neurology

Narrative Review: Headaches After Reversible Cerebral Vasoconstriction Syndrome

Yu-Hsiang Ling et al.

CURRENT PAIN AND HEADACHE REPORTS (2020)

Article Medicine, General & Internal

Reversible cerebral vasoconstriction syndrome: the importance of follow-up imaging within 2 weeks

Kiyomitsu Fukaguchi et al.

ACUTE MEDICINE & SURGERY (2020)

Review Clinical Neurology

Reversible Cerebral Vasoconstriction Syndrome: A Diagnostic Imaging Review

Tina M. Burton et al.

STROKE (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Acute Headache in the Emergency Setting

Melike Guryildirim et al.

RADIOGRAPHICS (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome Distinct Clinical Entities with Overlapping Pathophysiology

Alex Levitt et al.

RADIOLOGIC CLINICS OF NORTH AMERICA (2019)

Article Neurosciences

The Spectrum of Nontraumatic Convexity Subarachnoid Hemorrhage

Rachel Forman et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2019)

Review Obstetrics & Gynecology

Neurovascular disorders in pregnancy: A review

Julie Roth et al.

OBSTETRIC MEDICINE (2019)

Review Radiology, Nuclear Medicine & Medical Imaging

Reversible cerebral vasoconstriction syndrome: an important and common cause of thunderclap and recurrent headaches

M. T. Arrigan et al.

CLINICAL RADIOLOGY (2018)

Article Behavioral Sciences

Prediction of vascular abnormalities on CT angiography in patients with acute headache

Imanda M. E. Alons et al.

BRAIN AND BEHAVIOR (2018)

Article Clinical Neurology

Vascular wall imaging in reversible cerebral vasoconstriction syndrome - a 3-T contrast-enhanced MRI study

Chun-Yu Chen et al.

JOURNAL OF HEADACHE AND PAIN (2018)

Article Clinical Neurology

Cerebral vasomotor reactivity in reversible cerebral vasoconstriction syndrome

Mehmet Akif Topcuoglu et al.

CEPHALALGIA (2017)

Article Clinical Neurology

Coexisting vascular lesions in reversible cerebral vasoconstriction syndrome

M. Akif Topcuoglu et al.

CEPHALALGIA (2017)

Article Clinical Neurology

Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome

Aneesh B. Singhal et al.

NEUROLOGY (2017)

Review Clinical Neurology

Reversible Cerebral Vasoconstriction Syndrome in Pediatrics: A Case Series and Review

Samantha W. Coffino et al.

JOURNAL OF CHILD NEUROLOGY (2017)

Article Clinical Neurology

Initial vasodilatation in a child with reversible cerebral vasoconstriction syndrome

Yoshitsugu Oikawa et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2017)

Article Clinical Neurology

Cerebral endothelial dysfunction in reversible cerebral vasoconstriction syndrome: a case-control study

Hyun Ah Choi et al.

JOURNAL OF HEADACHE AND PAIN (2017)

Article Clinical Neurology

Reversible cerebral vasoconstriction syndrome in puerperium: A prospective study

Gian Paolo Anzola et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)

Article Dentistry, Oral Surgery & Medicine

Postpartum Headache: A Prospective Study

Gian Anzola et al.

Journal of Oral & Facial Pain and Headache (2017)

Article Clinical Neurology

Long-term outcomes after reversible cerebral vasoconstriction syndrome

Seby John et al.

CEPHALALGIA (2016)

Article Clinical Neurology

Distinguishing clinical and radiological features of non-traumatic convexal subarachnoid hemorrhage

J. Graff-Radford et al.

EUROPEAN JOURNAL OF NEUROLOGY (2016)

Article Clinical Neurology

Hemorrhagic Reversible Cerebral Vasoconstriction Syndrome Features and Mechanisms

Mehmet A. Topcuoglu et al.

STROKE (2016)

Article Clinical Neurology

Gender and hormonal influences in reversible cerebral vasoconstriction syndrome

Mehmet A. Topcuoglu et al.

EUROPEAN STROKE JOURNAL (2016)

Review Clinical Neurology

Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course

T. R. Miller et al.

AMERICAN JOURNAL OF NEURORADIOLOGY (2015)

Review Medicine, General & Internal

Reversible cerebral vasoconstriction syndrome

Z. Calic et al.

INTERNAL MEDICINE JOURNAL (2015)

Article Emergency Medicine

Reversible cerebral vasoconstriction syndrome at the emergency department

Taerim Kim et al.

CLINICAL AND EXPERIMENTAL EMERGENCY MEDICINE (2015)

Editorial Material Clinical Neurology

Hyperintense vessels: An early MRI marker of reversible cerebral vasoconstriction syndrome?

Shih-Pin Chen et al.

CEPHALALGIA (2014)

Article Clinical Neurology

A common cause of sudden and thunderclap headaches: reversible cerebral vasoconstriction syndrome

Yu-Chen Cheng et al.

JOURNAL OF HEADACHE AND PAIN (2014)

Article Clinical Neurology

Association between reversible cerebral vasoconstriction syndrome and thrombotic thrombocytopenic purpura

Prakash R. Paliwal et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)

Article Clinical Neurology

Subarachnoid and intra-cerebral hemorrhage in young adults: Rare and underdiagnosed

B. Mathon et al.

REVUE NEUROLOGIQUE (2014)

Article Clinical Neurology

Clinical Worsening in Reversible Cerebral Vasoconstriction Syndrome

Brian S. Katz et al.

JAMA NEUROLOGY (2014)

Article Clinical Neurology

Reversible cerebral vasoconstriction syndrome: rare or underrecognized in children?

Rebecca Probert et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2013)

Article Clinical Neurology

Reversible cerebral vasoconstriction syndrome associated with brain parenchymal hemorrhage

Yuko Kazato et al.

BRAIN & DEVELOPMENT (2012)

Review Clinical Neurology

Reversible cerebral vasoconstriction syndrome

Anne Ducros

LANCET NEUROLOGY (2012)

Article Clinical Neurology

Variable Presentations of Postpartum Angiopathy

Jennifer E. Fugate et al.

STROKE (2012)

Article Clinical Neurology

Reversible Cerebral Vasoconstriction Syndromes Analysis of 139 Cases

Aneesh B. Singhal et al.

ARCHIVES OF NEUROLOGY (2011)

Article Clinical Neurology

Reversible cerebral vasoconstriction syndrome: an under-recognized clinical emergency

Shih-Pin Chen et al.

Therapeutic Advances in Neurological Disorders (2010)

Article Clinical Neurology

Transcranial color Doppler study for reversible cerebral vasoconstriction syndromes

Shih-Pin Chen et al.

ANNALS OF NEUROLOGY (2008)

Article Clinical Neurology

Bath-related thunderclap headache: a study of 21 consecutive patients

S-J Wang et al.

CEPHALALGIA (2008)

Article Clinical Neurology

Postpartum cervicocephalic artery dissection

Marcel Arnold et al.

STROKE (2008)

Review Medicine, General & Internal

Narrative review: Reversible cerebral vasoconstriction syndromes

Leonard H. Calabrese et al.

ANNALS OF INTERNAL MEDICINE (2007)

Article Clinical Neurology

A pediatric case of reversible segmental cerebral vasoconstriction

A Kirton et al.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2006)

Article Rheumatology

Benign angiopathy of the central nervous system: Cohort of 16 patients with clinical course and long-term followup

RA Hajj-Ali et al.

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2002)